Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa-Reference-Cited by-同舟云学术

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa

Published:2017-08-03 Issue:11 Volume:72 Page:3141-3148
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Hunt Gillian M¹²^ORCID,Dokubo E. Kainne³,Takuva Simbarashe¹²,de Oliveira Tulio⁴⁵,Ledwaba Johanna¹,Dube Nomathemba¹,Moodley Pravi⁶,Sabatier Jennifer³,Deyde Varough⁷,Morris Lynn¹²,Raizes Elliot³

Affiliation:

1. Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa

2. Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

3. Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, USA

4. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

5. Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa

6. Department of Virology, National Health Laboratory Services/University of KwaZulu-Natal, South Africa

7. US Centers for Disease Control and Prevention, Pretoria, South Africa

Funder

Centers for Disease Control and Prevention

South African Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/11/3141/21359253/dkx252.pdf

Reference30 articles.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, predictors and geospatial patterns of HIV drug resistance in South Africa: Insights from the 2017 national HIV household survey;2024-05-28

2. Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-03-11

3. Prevalence and trends of advanced HIV disease among antiretroviral therapy-naïve and antiretroviral therapy-experienced patients in South Africa between 2010-2021: a systematic review and meta-analysis;BMC Infectious Diseases;2023-08-22

4. Viraemia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy;2023-06-19

5. Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens;AIDS;2022-08-10